Pharmacy
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Pharmacy
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Management
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Messages

The Best of 2009
D Scott Cunningham MD, PhD, MDLinx Oncology
  See all

Articles: Basic Science



Latest (2) Month's Top Read Top 50 of Year  
Receive free subspecialty "5-minute updates" via email

Prior Articles


The inhibitor of protein arginine methyltransferases, ami-1 is a potent scavenger of nox-derived superoxide
Molecular Pharmacology, 11/20/09
Sponsor
novel roscovitine derivative potently induces G1-phase arrest in PDGF-BB-activated vascular smooth muscle cells
Molecular Pharmacology, 11/20/09
Effective vaginal DNA delivery with high transfection efficiency is a good system for induction of higher local vaginal immune responses
Journal of Pharmacy and Pharmacology, 11/18/09
Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite
British Journal of Clinical Pharmacology, 11/16/09
Multicenter Analysis of the SLC6A3/DAT1 VNTR Haplotype in Persistent ADHD Suggests Differential Involvement of the Gene in Childhood and Persistent ADHD
Neuropsychopharmacology, 11/16/09
Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity
Pharmacology & Therapeutics, 11/16/09
Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses
Clinical and Experimental Pharmacology and Physiology, 11/13/09
Structure and function of heterotrimeric g protein-regulated rho guanine nucleotide exchange factors
Molecular Pharmacology, 11/13/09
G Protein Mediated Inhibition of Cav3.2 T-type Channels Revisited
Molecular Pharmacology, 11/13/09
Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite
Drug Metabolism and Disposition, 11/12/09
If the KI is defined by the free energy of binding to P-gp, what kinetic parameters define the IC50 for the MDCKII-hMDR1 confluent cell monolayer
Drug Metabolism and Disposition, 11/12/09
Human Cytochrome P450 Oxidoreductase Deficiency Caused by the Y181D Mutation: Molecular Consequences & Rescue of Defect
Drug Metabolism and Disposition, 11/12/09
Putative Transmembrane Domain 12 of the Human Organic Anion Transporter hOAT1 Determines Transporter Stability and Maturation Efficiency
Journal of Pharmacology and Experimental Therapeutics, 11/12/09
Quantitative prediction and clinical observation of a cyp3a inhibitor-based drug-drug interactions with mln3897, a potent ccr1 antagonist
Journal of Pharmacology and Experimental Therapeutics, 11/12/09
Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia
Clinical Pharmacology & Therapeutics, 11/12/09
Analgesic omega-conotoxins cvie and cvif selectively and voltage dependently block recombinant and native n-type calcium channels
Molecular Pharmacology, 11/11/09
Quercetin and naringenin transport across human intestinal Caco-2 cells
Journal of Pharmacy and Pharmacology, 11/10/09
An epilepsy-related region in the GABAA receptor mediates long-distance effects on GABA and benzodiazepine binding sites
Molecular Pharmacology, 11/10/09
Identification and Characterization of a Small Molecule Antagonist of Human VPAC2 Receptor
Molecular Pharmacology, 11/10/09
CCR2 receptor ligands inhibit Cav3.2 T-type calcium channels
Molecular Pharmacology, 11/10/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
250 Available Pages
First    Prev    5      6      7      8      9      10      11      12      13      14      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Pharmacy Articles Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.